Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry-Reference-Cited by-同舟云学术

Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry

Published:2021-09 Issue: Volume:154 Page:157-166
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Yamada Akimitsu^ORCID,Kumamaru Hiraku,Shimizu Chikako,Taira Naruto,Nakayama Kanako,Miyashita Mika,Honma Naoko,Miyata Hiroaki,Endo Itaru,Saji Shigehira,Sawaki Masataka

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. . Cancer incidence of Japan 2017,2017

2. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Senkus;Ann Oncol,2015

3. NCCN guidelines updates: breast cancer;Giordano;J Natl Compr Canc Netw,2018

4. NCCN clinical practice guidelines in oncology: version 1,2020

5. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer;Muss;J Am Med Assoc,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan;Breast Cancer;2024-01-05

2. Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment;Frontiers in Oncology;2023-12-15

3. Annual report of the Japanese Breast Cancer Registry for 2019;Breast Cancer;2023-12-04

4. 2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-Year Mortality of Elderly Breast Cancer Patients in Japan;2023-10-31

5. Adherence to multidisciplinary team meeting recommendations in elderly patients with HER2-positive breast cancer;2023-07-10